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IntroductIon
Natural antibodies are distinct from the antibodies generated 
in response to infections. They are of the IgM and, to a lesser 
extent, class-switched isotypes, such as IgG3. IgM is unique 
among the antibody classes. It is highly evolutionarily con-
served and can be found in all living jawed vertebrates (Fla-
jnik, 2002). IgM secretion begins even before birth (van Furth 
et al., 1965), independent of all foreign antigen exposure, in-
cluding exposure to microbiota (Bos et al., 1988; Haury et al., 
1997). In contrast, class-switch recombination to IgG1, IgG2, 
and IgA is strongly enhanced after foreign antigen exposure, 
explainingreductions of these antibody isotypes in germ-free 
animals (Bos et al., 1988, 1989). Natural antibody-secreting 
B-1 cells appear to be specifically selected for self-reactivity 
(Hayakawa et al., 1999).
Natural IgM has several important protective functions. 
It suppresses autoantibody production by regulating B cell 
development and selection (Nguyen et al., 2015) and through 
clearance of self-antigens, such as cellular debris and apop-
totic cells (Boes et al., 2000; Ehrenstein et al., 2000; Notley et 
al., 2011; Nguyen et al., 2015). It also protects against bacterial 
and viral infections (Boes et al., 1998; Ochsenbein et al., 1999; 
Baumgarth et al., 2000; Alugupalli et al., 2003; Haas et al., 
2005; Choi and Baumgarth, 2008). It is still unclear, however, 
how natural IgM secretion is induced and regulated. Yet to 
harness the therapeutic potential of natural IgM, the cellular 
sources must be identified.
Several properties of natural IgM antibody-secreting 
cells (ASCs), including their phenotypes, the tissues they re-
side in, and their differentiation states, are subjects of debate. 
Lalor et al. (1989) demonstrated through the use of Ig allo-
type disparate chimeras that B-1 cells, not conventional B-2 
cells, are the main source of natural IgM secretion. Although 
many other studies have supported these findings (Baumgarth 
et al., 1999; Ohdan et al., 2000; Haas et al., 2005; Choi and 
Baumgarth, 2008; Gil-Cruz et al., 2009; Holodick et al., 2009; 
Choi et al., 2012), a recent study by Reynolds et al. (2015) 
suggested that fetal- but non-B-1 cell–derived plasma cells 
(PCs) in the BM are responsible for all natural IgM secretion. 
Others have found that marginal zone B cells are a source of 
some natural IgM (Ichikawa et al., 2015).
Among B-1 cells, some researchers have reported that 
CD5+ B-1a cells are the major source of natural IgM (Haas 
et al., 2005; Holodick et al., 2009), whereas others have sug-
gested that CD5neg B-1b cells are more important (Ohdan et 
al., 2000; Gil-Cruz et al., 2009). The contributions of perito-
neal cavity versus spleen and BM B-1 cells to steady-state nat-
ural IgM production have also been debated (Van Oudenaren 
et al., 1984; Ohdan et al., 2000; Watanabe et al., 2000; Tu-
mang et al., 2005; Holodick et al., 2010; Choi et al., 2012; 
Reynolds et al., 2015).
natural antibodies contribute to tissue homeostasis and protect against infections. they are secreted constitutively 
without external antigenic stimulation. the differentiation state and regulatory pathways that enable continuous natural 
antibody production by B-1 cells, the main cellular source in mice, remain incompletely understood. Here we demonstrate 
that natural IgM-secreting B-1 cells in the spleen and bone marrow are heterogeneous, consisting of (a) terminally dif-
ferentiated B-1–derived plasma cells expressing the transcriptional regulator of differentiation, Blimp-1, (b) Blimp-1+, 
and (c) Blimp-1neg phenotypic B-1 cells. Blimp-1neg IgM-secreting B-1 cells are not simply intermediates of cellular 
differentiation. Instead, they secrete similar amounts of IgM in wild-type and Blimp-1–deficient (PrdM-1ΔEx1A) mice. 
Blimp-1neg B-1 cells are also a major source of IgG3. consequently, deletion of Blimp-1 changes neither serum IgG3 levels 
nor the amount of IgG3 secreted per cell. thus, the pool of natural antibody-secreting B-1 cells is heterogeneous and 
contains a distinct subset of cells that do not use Blimp-1 for initiation or maximal antibody secretion.
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Natural IgM-secreting cells produce constant serum 
levels of IgM throughout life, but the mechanisms of their 
maintenance are unknown. Terminal differentiation to the 
PC state after induction of B lymphocyte–induced matura-
tion protein 1 (Blimp-1) is required for the generation of 
long-lived B-2 cell–derived PCs (Shapiro-Shelef et al., 2003; 
Kallies et al., 2007). The importance of Blimp-1 for B-1 cell 
natural IgM production is less clear. Although Tumang et al. 
(2005) found that B-1 cells secrete IgM independently of 
Blimp-1, Savitsky and Calame (2006) and Fairfax et al. (2007) 
reported that B-1 cells require Blimp-1 for secretion. Mice 
with Blimp-1–deficient B cells have reduced serum levels of 
natural IgM (Savitsky and Calame, 2006). It is unclear why 
Blimp-1 deficiency causes reductions rather than loss of nat-
ural IgM, but this could be due either to decreased IgM se-
cretion among all natural IgM ASCs or decreased secretion 
by some (but not all) ASCs. The first possibility is consistent 
with the role of Blimp-1 in B-2 cells (Nutt et al., 2015) but 
is difficult to reconcile with the need of B-1 cells for mainte-
nance via self-renewal (Lalor et al., 1989). Interestingly, sharks 
seem to have two populations of natural IgM-secreting cells 
that differ in Blimp-1 expression (Castro et al., 2013), pro-
viding an evolutionary precedent for Blimp-1–independent 
generation of IgM secretion.
Less is known about natural IgG3. A recent study re-
ported on the presence of anticommensal IgG3 (Koch et al., 
2016), but natural IgG3–secreting cells in germ-free mice 
(Van Oudenaren et al., 1984; Bos et al., 1988) have been re-
ported as well. B-1 cell–deficient Btk knockout mice lack 
serum IgG3, suggesting B-1 cells as a possible source (Khan 
et al., 1995). However, secretion of IgG3 has been studied 
primarily as a T-independent antibody formed early during 
an immune response (Perlmutter et al., 1978; Mongini et al., 
1981; Gavin et al., 1998; Honda et al., 2009; Colombo et al., 
2010). The source of natural IgG3 ASCs and the regulation of 
their differentiation have not yet been studied.
Our study revealed the coexistence of two main B-1 
lineage–derived natural ASC types in the BM and spleens of 
mice: CD19neg CD138+ Blimp-1hi PCs (B-1PCs) and classi-
cal, mostly CD138neg B-1 cells. Although the former are de-
pendent on Blimp-1 for maximal natural Ig production, only 
some IgM-secreting B-1 cells express and require Blimp-1; 
most IgG3-producing cells neither express Blimp-1 nor re-
quire it for steady-state antibody production. Thus, natural 
antibody production is provided by multiple B-1 lineage–
derived subsets of ASCs, some maximally producing anti-
bodies without Blimp-1–mediated terminal differentiation.
rEsults
natural IgM is secreted by B-1 cells and 
Pcs in the spleen and BM
We first investigated natural antibodies in adult, germ-free 
mice. Consistent with previous studies showing that natural 
IgM is produced independently of exposure to microbiota 
(Bos et al., 1988; Haury et al., 1997), serum IgM concentra-
tions, as measured by ELI SA, were comparable between 
SPF and germ-free mice, as were the levels of IgG3, whereas 
IgA concentrations had decreased as expected (Fig. 1 A). 
Consistent with the serum antibody levels, frequencies of 
IgM-secreting cells in the spleen and BM were comparable be-
tween SPF and germ-free mice (Fig. 1 B), whereas they were 
rare in the peritoneal cavity of both types of mice, consistent 
with previous findings (Ohdan et al., 2000; Watanabe et al., 
2000; Choi et al., 2012). We define the IgM and IgG3 present 
in germ-free mice as “natural antibodies” and conclude that 
spontaneous IgM and IgG3 secretion of SPF-housed mice 
largely represents natural IgM and IgG3 generation.
To conduct an unbiased analysis of the major tissue 
sources of natural IgM ASCs, we compared spontaneous IgM 
secretion in multiple organs using ELI SPOT. Consistent with 
the results of previous studies (Van Oudenaren et al., 1984; 
Bos et al., 1988; Choi et al., 2012) but in contrast to the results 
of the study conducted by Reynolds et al. (2015), the data 
revealed that both the spleen and BM contain the highest 
fractions of IgM ASCs (Fig. 1 C, left), whereas other tissues 
contribute less than 5%. Thus, the spleen and BM are the two 
main sites of natural IgM secretion. The ELI SPOT assay did 
not record simply “shedding” of surface-expressed IgM BCR, 
as IgM ELI SPOTs were absent after culture of spleen and 
BM from µs−/− mice, which express the IgM BCR but lack 
secreted IgM (Fig. 1 C, right).
To identify and characterize natural IgM-secreting cells, 
we FACS-sorted live cells from both the spleen and BM that 
either did or did not express CD43 and lacked expression 
of lineage markers for T cells (Thy1), macrophages (F4/80), 
granulocytes (Gr-1), and natural killer cells (NK1.1; referred 
to as “dump” markers). In the B cell lineage, CD43 is ex-
pressed on PCs and on B-1 cells, two sources previously 
implicated as main producers of natural IgM (Lalor et al., 
1989; Choi et al., 2012; Holodick et al., 2014; Reynolds et 
al., 2015). Confirming the results of those previous studies, 
CD43neg cells did not form IgM ASCs in the BM, and only 
a very small percentage (0.2%) formed ASCs in the spleen 
(unpublished data). We therefore focused exclusively on the 
CD43+ cell compartment. Further separation of CD43+ cells 
into four subsets based on expression of CD19 and IgM 
(Fig. 1 D) demonstrated that IgM secretion was restricted to 
surface IgM+ cells (Fig. 1 E), as previously noted (Reynolds 
et al., 2015). Among those, both CD19+ and CD19neg cells 
contained IgM-secreting cells. The CD19neg fraction made up 
0.08 ± 0.06% of the CD43+IgDneg cells in the BM and made 
up 0.5 ± 0.01% in the spleen. Almost all formed IgM ASCs 
by ELI SPOT (Fig. 1 E). The CD19+ fraction made up 5 ± 
1% of the CD43+IgDneg cells in the BM and made up 36 ± 
5% in the spleen. Of the CD19+ fraction, 0.5 ± 0.2% in the 
BM and 4 ± 0.3% in the spleen formed IgM ASCs (Fig. 1 E).
The CD19negIgM+ cells expressed the PC marker 
CD138 (Fig. 1 F). This population of CD19negIgM+CD43+ 
IgDnegCD138+ PCs in the BM is similar to that recently 
identified by Reynolds et al. (2015) as natural IgM PCs. 
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Figure 1. Phenotypic B-1 cells and Pcs secrete natural IgM predominantly in the spleen and BM. (A) Concentration ± SD (µg/ml) of IgM, IgG3, and 
IgA in serum of germ-free and SPF-maintained Swiss Webster mice (n = 8–15) measured by ELI SA. (B) Number ± SD of IgM ASCs as determined by ELI SPOT 
(n = 7 for germ-free mice and n = 4 for SPF mice). Results are combined (A) or representative (B) of two independent experiments. (C, left) Number ± SD of 
IgM ASCs in multiple tissues of wild-type neonatal chimeras as measured by ELI SPOT (n = 3–6). IgMa and IgMb spots were added for each mouse. (C, right) 
Representative ELI SPOT demonstrating IgM secretion by spleen and BM cells of C57BL/6 control mice and mice lacking secretory IgM (µs−/− mice; n = 3). 
Numbers indicate total input cells. Representative of two independent experiments. (D) Gating strategy for CD19+ IgM+/neg cells after selecting “nondump,” 
CD43+, IgDlo/neg cells. Values shown in all FACS plots represent percentage within parent population. (E) Frequency ± SD of IgM ASCs among live, nondump, 
CD43+, IgDlo/neg cells in BM (n = 2 for CD19negIgM+; n = 5 for the others) and spleen (n = 6–7 for IgM+; n = 2–3 for IgMneg). The dashed lines indicate limit of 
detection. Results are representative of two independent experiments. (F) Representative FACS histograms of CD138 expression among BM CD19+IgM+ (B-1 
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In contrast, among the CD19+IgM+ cells in the BM and 
spleen, most were CD138low or CD138neg. Their phenotype 
(CD19+CD43+IgM+IgDneg/lo) was that of B-1 cells, which 
have previously been shown to generate natural IgM (Choi 
et al., 2012). Thus, we found two major natural IgM secre-
tors: CD19negIgM+CD43+IgDnegCD138+ and CD19+CD43+, 
mostly CD138neg B-1 cells. Because B-1 cells are more plen-
tiful than PCs in both the spleen and BM, when both the 
frequency in each tissue and the frequency of ASC formation 
among those are considered, B-1 cells formed a mean of 33% 
of the IgM ASCs in the BM and 76% in the spleen (Fig. 1 G). 
Thus, we conclude that natural IgM is generated from two 
cell sources: PCs and classical B-1 lymphocytes.
natural IgM-secreting B-1 cells and Pcs originate 
from the same population
Previous studies on chimeric mice depleted of B cells and 
reconstituted at birth with B-1 cells of a different Ig allotype 
(Lalor et al., 1989) showed that IgM ASCs were mostly from 
the B-1 cell donor and provided normal levels of serum IgM, 
suggesting that all natural IgM ASCs are derived from the B-1 
lineage. To determine whether natural IgM PCs are B-1 lin-
eage cells, we created neonatal chimeric mice by reconstitut-
ing anti-IgMa–treated CD45.2 Igha neonatal recipients with 
both Ig and CD45 allotype disparate, magnetic bead–purified 
B-1 cells (Fig. 2 A). After 6 wk of antibody treatment and 
another 6 wk to allow B-2 cell regeneration, we found that 
both B-1 cells and CD19negIgM+CD138+ PCs were gener-
ated from IgMb- and CD45.1-positive peritoneal cavity B-1 
donor cells in BM (Fig. 2 B) and the spleen (Fig. 2 C). Serum 
analysis showed that the donor-derived B-1PCs and B-1 cells 
secreted comparable amounts of IgM to those of nonmanip-
ulated control mice (Fig. 2 D). Thus, PCs (B-1PCs) and B-1 
cells are repopulated from adult-derived peritoneal cavity B-1 
donor cells in neonatal chimeras. The data provide further 
evidence that most, if not all, natural IgM-secreting cells be-
long to the B-1 lineage and demonstrate that some B-1 cells 
undergo terminal PC differentiation.
the majority of B-1 cells lack Blimp-1 expression
Terminal differentiation, regulated by increased expression of 
the transcriptional regulator Blimp-1 (Shapiro-Shelef et al., 
2003), drives increased Ig secretion, suggesting that natural 
IgM ASCs may express this transcription factor. However, 
B-1 cells are known to develop primarily from fetal and neo-
natal cells and to be maintained by self-renewal. Because ter-
minal differentiation would render cells unable to proliferate, 
we studied Blimp-1 expression among natural IgM-secreting 
cells using Blimp-1 YFP reporter mice (Rutishauser et al., 
2009; Fooksman et al., 2010). In BM and the spleen, the IgM+ 
B-1PCs were uniformly Blimp-1 YFPhi (Fig. 3, A and B). In 
contrast, B-1 cells were almost all Blimp-1 YFPneg in the BM 
(Fig. 3 A), whereas the spleen contained a small percentage of 
Blimp-1 YFP-expressing B-1 cells (Fig. 3 B).
We next looked at Blimp-1 expression and IgM secre-
tion among B-1a and B-1b cells in BM, the spleen, and a site 
that contained only a few spontaneous IgM-secreting cells: 
the peritoneal cavity (Fig. 3, C and D). Again, we found very 
few Blimp-1+ B-1 cells in the BM (Fig.  3  D). The spleen 
contained a small but distinct population of mostly CD5neg 
B-1b cells that expressed high levels of Blimp-1 (Fig. 3 D). 
In contrast to the results of a previous study (Tumang et al., 
2005), the peritoneal cavity contained a distinct population 
of mostly CD5+ B-1a cells that expressed intermediate levels 
of Blimp-1 (Fig. 3 D). Their Blimp-1 expression was lower 
than that of the splenic B-1b Blimp-1+ cells (Fig. 3 D). To 
determine whether these cells might contain a small number 
of peritoneal cavity IgM ASCs (Fig. 1 C), peritoneal cavity 
Blimp-1int B-1a cells were sorted for ELI SPOT assays. There 
was no enrichment for IgM secretion (not depicted). Thus, 
intermediate expression of Blimp-1 is not a marker of IgM 
ASCs. Furthermore, the frequencies of Blimp-1hi–expressing 
B-1 cells in BM and the spleen (Fig.  3  E) did not appear 
to correlate with the frequencies of B-1 cell IgM ASCs 
identified in each tissue by ELI SPOT (Fig.  1  E), suggest-
ing that both Blimp-1hi and Blimp-1neg B-1 cells contribute 
to natural IgM secretion.
Blimp-1 expression enhances but is not required 
for natural IgM secretion
To examine the impact of Blimp-1 expression on IgM secre-
tion by B-1 cells, we studied B cell–specific prdm1−/− mice. 
Previous studies had used CD19cre/+ prdm-1flx/flx mice. How-
ever, B-1a cell development is negatively affected when CD19 
levels are reduced (Engel et al., 1995; Rickert et al., 1995; 
Haas et al., 2005) and CD19cre/+ mice have reduced CD19 
expression due to the replacement of one allele—CD19—by 
the Cre gene. Consistent with these findings, control mice 
expressing CD19cre/+ alone showed a defective B-1 compart-
ment when compared with wild-type C57BL/6 mice, but 
one that was similar to that of CD19cre/+ PRDM-1flx/flx mice 
(Fig. 4, A and B). In addition, CD19cre/+–only controls had 
approximately twofold higher frequencies of B-1PCs com-
pared with C57BL/6 mice (Fig. 4 C). The defect in B cell 
development in CD19cre/+ (with or without PRDM-1flx/flx) 
mice affected B-1 but not B-2 cells (Fig. 4 D). Thus, both 
the CD19cre/+ and CD19cre/+ PRDM-1flx/flx mice harbored 
abnormal B-1 cell pools and are ill-suited for B-1 cell studies.
We therefore chose to study PRDM-1ΔEx1A mice. 
These mice lack exon 1 of prdm1, which contains the B 
cells) and CD19neg IgM+ (PCs). (G) Contribution of B-1 cells and PCs to total IgM ASCs in indicated tissues was determined by multiplying the percentage of 
IgM ASCs in each population by the frequency of that population in the tissue (n = 9). Results are combined from three to four independent experiments. 
Statistics in A and B were done using an unpaired Student’s t test (****, P < 0.00005).
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cell–specific prdm-1 promoter (Morgan et al., 2009). FACS 
analysis demonstrated minimal effects on B cell populations 
of this knockout in a steady state. B-1a and total B-1 cells in 
the spleens and BM of PRDM-1ΔEx1A mice were compara-
ble to those of wild-type mice (Fig. 4, A–C; and Fig. 5 C) 
but distinct from those with CD19 haploinsufficiency 
(Fig.  4, A–C). B-1PC populations were reduced in some, 
but not all, analyses (Figs. 4 C and 5 C). BM B cell develop-
ment also appeared to be unaffected (Fig. 5 A), resulting in 
overall normal frequencies of splenic transitional, follicular, 
and marginal-zone B cell frequencies (Fig. 5 B). Both the 
CD19cre/+ PRDM-1flx/flx and the PRDM-1ΔEx1A mice har-
bored B-1PCs, which in wild-type mice express high levels 
of Blimp-1. However, B-1PCs in the PRDM-1ΔEx1A mice 
had increased turnover rates compared with the B-1PCs of 
controls (Fig.  5, D and E), indicating their shortened life 
spans, as reported previously for B-2PCs (Kallies et al., 2007).
As expected, and in contrast to peritoneal cavity B-1 cells 
from control C57BL/6 mice and from Blimp-1 YFP reporter 
mice, B-1 cells from PRDM-1ΔEx1A mice did not up-regulate 
prdm1 after stimulation with LPS in vitro (Fig. 5 F). This 
was assessed by qRT-PCR for exon 6 of Blimp-1, which is 
present in all Blimp-1 transcripts. Previous studies had shown 
the lack of Blimp-1 protein expression in B cells by West-
ern blot (Morgan et al., 2009). Thus, exon 1 deletion did 
not lead to transcription of prdm1 from other start sites in 
PRDM-1ΔEx1A B cells. The cultured PRDM-1ΔEx1A cells se-
creted less IgM, both with and without stimulation, com-
pared with cells from Blimp-1 YFP and C57BL/6 control 
mice (Fig. 5 G), the latter showing comparable Blimp-1 gene 
expression and IgM production (Fig. 5, F and G). Importantly, 
however, PRDM-1ΔEx1A B-1 cells did strongly increase IgM 
production after LPS stimulation with fold inductions similar 
to those of C57BL/6 controls (133× in controls vs. 164× in 
Figure 2. natural IgM-secreting Pcs are of B-1 cell origin. (A, left) Neonatal chimeras were created to differentiate B-1 and B-2 cells and their se-
creted product by their Ig allotype. Neonatal Igha/CD45.2 C57BL/6 mice were treated from birth for 6 wk with anti-IgMa (DS.1) and received magnetic bead 
(autoMACS)–enriched donor Ighb/CD45.1 peritoneal cavity cells (PerC, right) within a few days of birth. Values shown in all FACS plots represent percentage 
within parent population. FMO, fluorescence minus one control stains for IgM. After the end of treatment, mice are rested for at least another 6 wk to 
allow for B-2 cell reconstitution. Resulting chimeras have IgMb/CD45.1 donor B-1 cells and IgMa/CD45.2 host B-2 cells. (B and C) Shown are 5% contour 
FACS plots of Ig allotype chimeric mice with CD45.2 IgMa conventional B cells and (CD45.1, IgMb) peritoneal cavity donor B-1 cells. (B) BM and (C) spleen 
PC and B-1 cells among CD45.1+ cells. Plots are representative of three mice. (D) B-1–derived serum IgMb concentrations ± SD (mg/ml) of chimeras and 
control C57BL/6 (IgMb) nontreated mice as measured by ELI SA (n = 3). No significant difference between groups, as assessed by an unpaired Student’s t test. 
Results in B and D are representative of three independent experiments, two of which used FACS-sorted B-1 cells in place of autoMACS-purified B-1 cells.
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PRDM-1ΔEx1A mice; Fig. 5 G). Thus, peritoneal cavity B-1 
cells from PRDM-1ΔEx1A mice, although they secreted less 
IgM after LPS stimulation than their wild-type counterparts, 
nonetheless significantly increased IgM secretion in response 
to LPS stimulation without up-regulating Blimp-1.
Consistent with reductions in total IgM secretion in 
vitro and consistent with the results of a previous study (Sha-
piro-Shelef et al., 2003), PRDM-1ΔEx1A mice had two- to 
threefold reduced serum IgM levels compared with the con-
trols (Fig. 5 H). Thus, Blimp-1 expression is required for 
some, but not all, natural IgM secretion. To test whether B-1 
cell-intrinsic Blimp-1 expression is required for natural IgM 
secretion in vivo, we generated neonatal Ig allotype chime-
ras by reconstituting B cell–depleted Igha wild-type mice 
with allotype-mismatched peritoneal cavity B cells from ei-
ther the controls or PRDM-1ΔEx1A (both Ighb) mice. Mice 
reconstituted with the PRDM-1ΔEx1A B-1 cells had signifi-
cant reductions of serum IgMb levels compared with those 
reconstituted with control B-1 cells. As expected, the host 
cell compartment contributed similar small amounts of IgM 
in both groups (Fig. 5 I). Thus, the decreased natural serum 
IgM levels in the PRDM-1ΔEx1A mice are due to a lack of 
Blimp-1 expression in the B-1 compartment. Significant 
levels of serum IgM remained in both PRDM-1ΔEx1A mice 
(Fig. 5 H) and chimeric mice, with Blimp-1 deficiency only 
in the B-1 compartment (Fig. 5 I).
To determine whether the IgM secreted in PRDM-1ΔEx1A 
mice is functional or qualitatively different from the IgM 
secreted in control mice, we infected mice with the in-
fluenza virus, against which natural IgM is protective 
(Baumgarth et al., 2000). Viral load was increased ∼100-fold 
in the PRDM-1ΔEx1A mice compared with the controls 
at 24  h after infection (Fig.  5  J). However, when B cell– 
deficient µMT mice were injected with equal amounts of 
IgM from either the control or PRDM-1ΔEx1A mice, viral 
lung loads were reduced to similar levels compared with 
nonreconstituted µMT mice (Fig. 5 K). Thus, natural IgM 
secreted in the absence of Blimp-1 expression is functional 
and can neutralize the influenza virus comparably to that 
of Blimp-1–dependent IgM.
Figure 3. the majority of B-1 cells lack 
Blimp-1 expression. Representative FACS 
plots showing YFP (Blimp-1) and CD138 stain-
ing among CD19neg IgM+CD43+ B-1PC and 
CD19+IgM+ IgDlo/neg CD43+ B-1 cells in (A) BM 
and (B) the spleen. Values shown in all FACS 
plots represent percentage within parent pop-
ulation. (C) Representative FACS gating for 
peritoneal cavity B-1 cells. (D) Blimp-1 YFP 
expression among B-1 cells in BM, spleen, and 
peritoneal cavity was defined as either nega-
tive, intermediate, or high. FMO, fluorescence 
minus one control stains for IgM (C) and CD5 
(D), respectively. (E) Frequency ± SD of Blimp-1 
YFP high, intermediate, and negative cells 
among B-1a (left) and B-1b (right) cells in the 
spleens, BM, and peritoneal cavities of C57BL/6 
mice (n = 4–10). Results are pooled from at 
least three independent experiments.
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Identification of splenic natural IgM Asc subsets with 
differing requirements for Blimp-1
Decreased serum IgM concentrations in the PRDM-1ΔEx1A 
mice could be explained by reduced natural IgM produc-
tion per ASCs, similar to the dose effects of Blimp-1 for 
B-2–derived ASCs (Shapiro-Shelef et al., 2003). Alternatively, 
Blimp-1–dependent ASCs might be lost in these mice, whereas 
Blimp-1–independent IgM production remains intact.
To distinguish between these possibilities, we first stud-
ied the role of Blimp-1 in the spleen, which contains both 
Blimp-1hi B-1PCs and a distinct population of Blimp-1hi 
B-1b cells (Figs. 3 and 6 A). Additionally, we separated these 
populations into B-1a and B-1b cells because they demon-
strated distinct Blimp-1 expression patterns (Fig. 3, D and E). 
A much higher frequency of Blimp-1hi B-1 cells, both B-1a 
and B-1b, formed IgM ASCs compared with the Blimp-1neg 
cells. However, a subset of Blimp-1neg B-1 cells also formed 
IgM ASCs (Fig. 6 B). Among the Blimp-1hi B-1 cells, B-1b 
cells formed more ASCs than B-1a cells (Fig. 6 B) and were 
able to secrete more IgM per cell, as indicated by the larger 
maximum spot size on ELI SPOT (Fig.  6  C). Interestingly, 
Blimp-1 expression levels among Blimp-1+ B-1b cells were 
higher than those of B-1a cells (Fig. 6 D), consistent with a 
dose-dependent effect of Blimp-1 expression on the secre-
tory ability of this B-1 subset, similar to that seen in B-2 cells 
(Shapiro-Shelef et al., 2003). Thus, many, but not all, B-1 cells 
in the spleen rely on Blimp-1 expression for IgM secretion. 
A distinct population of splenic B-1 cells exists that seems to 
neither express Blimp-1 nor rely on this transcriptional regu-
lator for IgM secretion.
Consistent with those data, splenic IgM ASCs were 
decreased in the PRDM-1ΔEx1A mice (Fig.  6 E). Chimeric 
mice established with either control or PRDM-1ΔEx1A Ighb 
B-1 peritoneal cavity donor cells confirmed that the decrease 
in IgM ASCs was due to decreased ASC formation by B-1 
lineage– derived cells (Fig. 6 F). Correspondingly, IgM secre-
tion in cultures established with cells from the PRDM-1ΔEx1A 
chimeric mice showed a significant reduction compared with 
the controls (Fig.  6  G). Although overall ASC formation 
decreased, some cells were able to secrete normal amounts 
of IgM, as shown by similar maximum ELI SPOT spot 
sizes between control and PRDM-1ΔEx1A mice (Fig.  6  H). 
Thus, the decreases in serum IgM in PRDM-1ΔEx1A mice 
are due to reduced IgM secretion by some Blimp-1–de-
pendent IgM ASCs, whereas other Blimp-1–independent 
IgM ASCs secrete normally.
We then examined whether the decrease in ASC forma-
tion in the PRDM-1ΔEx1A mice was due chiefly to a reduction 
in the uniformly Blimp-1hi–expressing CD19negIgM+CD138+ 
B-1PCs (Fig. 3 A). Both B-1PC and B-1 cells were present in 
PRDM-1ΔEx1A mice, yet IgM ASC frequencies were decreased 
approximately twofold among both populations (Fig.  6  I). 
B-1PC and B-1 cells were also sorted from µs−/− mice and 
no spots were seen, demonstrating that the observed spots 
are not due to surface IgM shedding (not depicted). Because 
B-1a and B-1b cells differed in Blimp-1 expression levels, we 
performed ELI SPOT analysis separately on sorted B-1a and 
B-1b cells. B-1b IgM ASC formation was greatly decreased in 
the PRDM-1ΔEx1A mice (Fig. 6 J), consistent with the higher 
frequency of splenic IgM ASCs among Blimp-1+ B-1b cells 
compared with other B-1 cell populations (Fig. 6 B). However, 
among B-1b cells able to form ASCs, both mean and maximal 
spot sizes were similar to those formed by control cells (Fig. 6 K). 
Consistently across all experiments, splenic B-1a ASC forma-
Figure 4. cd19cre/+ PrdM1flox/flox mice are 
a poor model for B-1–specific knockouts. 
(A–D) FACS analysis of the spleens and BM 
of wild-type (C57BL/6), CD19cre/+, CD19cre/+ 
PRDM1flox/flox, and PRDM-1ΔEx1A mice (n = 4–5). 
Results are representative of two independent 
experiments. (A) Frequencies ± SD of B-1a 
among B-1 cells and (B) the number ± SD of 
B-1a cells and total B-1 cells. (C) Frequencies ± 
SD of B-1PCs among live cells and of (D) follic-
ular and marginal zone B-1 cells among B cells 
in the spleen. All statistics were done using an 
unpaired Student’s t test (*, P < 0.05; **, P < 
0.005; ***, P < 0.0005).
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Figure 5. Blimp-1 expression is not required for natural IgM secretion. (A-E) FACS analysis of the spleen and BM of C57BL/6 wild-type and 
PRDM-1ΔEx1A mice. Results are pooled from two (A-C, n = 8–9 mice) or three (D and E, n = 6) independent experiments. (A) Mean frequencies ± SD of 
developing B cells in BM according to the Hardy scheme (Hardy and Hayakawa, 2001): A, prepro; B, pro; C, late pro; C’, early pre; D, late pre; E, immature; 
F, mature B cells. (B) Mean frequencies ± SD of marginal-zone (MZ), follicular (FO), and transitional (T1, T2+T3) spleen B cells. (C) Mean frequencies ± SD 
of B-1 cells and B-1PCs. Mean percentage of cell turnover per day ± SD of B-1a, B-1b, and B-1PC cells, as determined by BrdU incorporation, in C57BL/6 
wild-type and PRDM-1ΔEx1A mice in (D) the spleen and (E) BM. (F) Mean relative expression of prdm1 relative to gapdh ± SD as measured by qRT-PCR (n = 
3–5 samples). (G) Concentrations of IgM ± SD (µg/ml) in supernatants (n = 6–12), before and after 3-d culture of peritoneal cavity B cells with or without 
LPS from C57BL/6 control, Blimp-1 YFP, and PRDM-1ΔEx1A mice. Results in F and G are pooled from two independent experiments. (H) Mean serum IgM ± 
SD (mg/ml) in control and PRDM-1ΔEx1A mice as determined by ELI SA (n = 5–6). Results are representative of more than three independent experiments. 
(I) Serum IgMa and IgMb (mg/ml) ± SD as measured by ELI SA (n = 12–14). Sera are from neonatal Ig allotype chimeras with IgMa wild-type controls, recon-
stituted with IgMb-expressing wild-type (control) or PRDM-1ΔEx1A peritoneal cavity donor B-1 cells. Results are pooled from three independent experiments. 
(J) Mean viral loads ± SD (PFUs) in the lungs of control and PRDM-1ΔEx1A mice as measured by qRT-PCR 24 h after infection with Influenza A/PR/8 (n = 4). 
(K) Mean viral loads ± SD (PFUs) in the lungs of µMT mice 24 h after infection. µMT mice were given equal amounts of immune serum IgM from either 
control or PRDM-1ΔEx1A mice or no serum (n = 3–5). Results in J and K are pooled from two independent experiments. All statistics were done using an 
unpaired Student’s t test (*, P < 0.05; **, P < 0.005; ***, P < 0.0005; ****, P < 0.00005).
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Figure 6. Identification of subsets of splenic natural IgM Ascs differing in their requirements for Blimp-1. (A) Sorting gates for Blimp-1 YFP 
among B-1a and B-1b splenocytes pregated as live, singlet, dumpneg CD19+CD43+IgMhiIgDlo/neg cells. (B) Mean frequencies ± SD of IgM ASCs among Blimp-1 
YFP+ (YFP+) and Blimp-1 YFPneg (YFP-) B-1a and B-1b cells in the spleen (n = 3–8). The dashed line represents the limit of detection. (C, top) Mean maximum 
IgM spot size ± SD (number of pixels) in each ELI SPOT well of sorted Blimp-1 YFP+ or YFPneg B-1a and B-1b cells (n = 3–8) and (C, bottom) representative 
ELI SPOT wells. Numbers indicate total input cells. Results in B and C are representative of two independent experiments. (D) Representative overlay histo-
grams of Blimp-1 YFP among YFP+ B-1a and B-1b cells. (E) Mean frequencies ± SD of IgM ASC splenocytes from control and PRDM-1ΔEx1A mice (n = 11) and 
(F) control and PRDM-1ΔEx1A IgMb peritoneal cavity donor chimeras (n = 4–9) as measured by ELI SPOT. Results in E and F are pooled from two independent 
experiments. (G) B-1–derived IgM ± SD (µg/ml) in supernatants of splenocytes from control and PRDM-1ΔEx1A B-1 peritoneal cavity donor chimeras as 
measured by ELI SA (n = 3–5). (H, left) Mean maximum IgM spot size ± SD (number of pixels) in each ELI SPOT well for control versus PRDM-1ΔEx1A mice 
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tion was low compared with that of B-1b (Fig. 6 J), and the 
few existing splenic B-1a ASCs required Blimp-1 for maximal 
secretion (Fig. 6, B, J, and K). We conclude that many B-1 cells 
in the spleen require Blimp-1 for maximum IgM secretion, 
whereas a small subset of B-1b cells secrete IgM independently 
of Blimp-1, demonstrating heterogeneity in the requirement 
for Blimp-1 expression among IgM-secreting splenic B-1 cells.
BM B-1Pcs, but not B-1 Ascs, require Blimp-1 
for maximal IgM secretion
The BM contains Blimp-1 YFP+ B-1PCs and largely Blimp-1 
YFPneg B-1 cells (Figs. 3 and 7 A). Consistent with those find-
ings, frequencies of FACS-purified IgM ASCs among total 
BM B-1a and B-1b cells and those depleted of any Blimp-1–
expressing cells were comparable (Fig.  7 B). Confirming 
that YFP expression correlated with prdm1 gene expression, 
qRT-PCR analysis conducted on FACS-sorted BM B-1 cells 
showed the absence of prdm1 mRNA, whereas PCs ex-
pressed prdm1 and expressed irf4 at levels higher than those 
of B-1 cells (Fig. 7 C).
Few genes other than Blimp-1/IRF-4 are known 
that regulate PC fate. One is zbtb20 (Chevrier et al., 2014). 
However, we did not find any difference in zbtb20 expres-
sion comparing nonsecreting follicular B cells with Blimp-1+ 
B-1PCs and BM B-1 cells (Fig. 7 C). Despite this, BM B-1 
cells expressed ∼100-fold more mRNA for the J chain than 
follicular B cells, indicating that they generate pentameric 
IgM (Fig. 7 C). Further support came from fluorescent im-
aging studies, which identified BM Blimp-1 YFPneg B-1 cells 
that contained intracellular IgM vesicles (Fig.  7 D), similar 
to the Blimp-1 YFP+ B-1PCs (Fig. 7 D). Thus, BM B-1 cells 
secrete IgM in the absence of known transcriptional regula-
tors of PC differentiation.
Unexpectedly, given the strong contribution of B-1PCs 
to IgM production in BM (Fig. 1 G), the number of IgM 
ASCs among total BM cells was comparable between the con-
trol and PRDM-1ΔEx1A mice (Fig. 8 A), as well as in neonatal 
chimeric mice reconstituted with control or PRDM-1ΔEx1A 
Ighb peritoneal cavity cells (Fig. 8 B). Furthermore, the mean 
ELI SPOT spot sizes formed by BM cells from control and 
PRDM-1ΔEx1A mice were also comparable (Fig.  8  C), as 
were the overall IgM secretion levels of BM cells in culture 
(Fig. 8 D). Thus, the lack of Blimp-1 expression in the B-1 
cell compartment did not seem to affect the frequencies of 
BM IgM ASCs, nor the amount of IgM secreted.
This prompted us to separately assess the effects of 
Blimp-1 deficiency on BM B-1PC and B-1 cells. As pre-
dicted, IgM ASC formation was significantly decreased 
among B-1PCs (Fig. 8 E). However, there was a significant 
compensatory increase of IgM ASCs among the B-1 cells 
(Fig. 8 E), explaining the similar IgM ASC numbers in the 
BM of PRDMΔEx1A and control mice. Sorting of BM B-1a 
and B-1b cells from the control and PRDM-1ΔEx1A mice for 
ELI SPOT analysis confirmed the higher frequencies of IgM 
ASCs among BM B-1a and B-1b cells in the PRDM-1ΔEx1A 
mice compared with the controls (Fig.  8  F). Their mean 
ELI SPOT spot sizes were similar to those of control mice, 
indicating similar IgM secretion per cell (Fig. 8 G). Blimp-1 
deficiency did not change the absolute number of B-1a and 
B-1b cells in the BM (Fig. 8 H); instead, the BM B-1 cell 
compartment appears to respond to reductions in local and/
or systemic IgM production with increased antibody secre-
tion without up-regulating Blimp-1.
natural IgG3 B-1 Ascs do not require 
Blimp-1 for maximal secretion
Intriguingly, serum IgG3, which is produced in the ab-
sence of microbial challenge (Fig.  1 A), was unchanged in 
PRDM-1ΔEx1A mice compared with control mice, whereas 
other IgG subtypes as well as IgA were decreased (Fig. 9 A). 
Similarly, IgG3 ASC formations in the spleen and BM were 
comparable (Fig. 9 B), as were mean ELI SPOT spot sizes, 
indicating similar secretion by individual cells (Fig. 9 C). To 
determine whether B-1 cells are the source of IgG3, we com-
pared serum IgG3 concentrations in the neonatal chimeras at 
the end of anti-IgM treatment, when donor-derived B-1 cells 
are the only B cells present (day 42), and again in the same 
chimeras after full reconstitution of the conventional B cell 
pool (day 97). Serum IgG3 levels in each of these mice were 
similar between day 42 and day 97, strongly indicating that 
most serum IgG3 is derived from B-1 cells (Fig. 9 D).
Consistent with a lack of Blimp-1 involvement in serum 
IgG3 production, the vast majority of IgG3+ B cells in the 
spleen lacked Blimp-1 YFP expression (Fig. 9 E, left). IgG3 
secretion occurred only among IgG3+ cells (Fig. 9 E, right) 
and among both of those, the few Blimp-1 YFP+ and the ma-
jority of Blimp-1 YFPneg cells formed IgG3 ASCs (Fig. 9 E, 
right). The frequencies of YFP+ cells exceeded the percent-
age of secretion seen among the YFPneg cells, excluding con-
tamination with YFP+ cells as a trivial explanation for IgG3 
secretion in the absence of Blimp-1. The IgG3+ YFPneg cells 
secreted similar amounts per cell compared with the IgG3+ 
YFP+ cells, as indicated by their similar spot sizes (Fig. 9 F). 
Together, our studies identify the significant and unique con-
tributions of Blimp-1–independent B cell ASCs to the pro-
duction of natural IgG3 and some natural IgM.
(n = 3) and (H, right) representative ELI SPOT wells. Numbers indicate total input cell numbers. Results are representative of two independent experiments. 
(I) Mean frequencies ± SD of IgM ASCs among splenic CD19neg IgM+ IgDlo/neg CD43+ CD138+ B-1PC and CD19+ IgM+ IgDlo/neg CD43+ B-1 cells (n = 9–10) and 
of (J) splenic B-1a and B-1b cells (n = 2–4) in control and PRDM-1ΔEx1A mice. (K, left) Mean maximum IgM spot size ± SD (number of pixels) in each ELI SPOT 
well of sorted Blimp-1 YFP+ and YFPneg B-1a and B-1b cells (n = 2–4) and (K, right) representative ELI SPOT wells. Results in I–K are representative of two 
independent experiments. Statistics in B and C and E–K were done using an unpaired Student’s t test (*, P < 0.05; **, P < 0.005; ***, P < 0.0005).
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dIscussIon
Our data identified two distinct sources of natural IgM: classi-
cal B-1 cells and B-1–derived PCs. B-1PCs and most splenic 
B-1 cells resemble B-2 cells in their requirement for Blimp-1 
for secretion. However, some classical B-1 cells, particularly 
those in BM, neither expressed nor required Blimp-1 for 
secretion. BM, but not splenic B-1 cells, responded to low 
serum IgM levels by increasing the percentage of cells that 
secreted IgM, not by increasing IgM production per cell. In 
PRDM-1ΔEx1A mice, this resulted in partial compensation 
for the loss of Blimp-1–dependent secretion by B-1PCs in 
the BM, where ASC numbers were comparable between 
Figure 7. BM B-1Pc, but not B-1 cells, require Blimp-1 for maximal IgM secretion. (A) Gating for total and Blimp-1 YFPneg (YFP-) B-1a and B-1b 
BM cells, pregated on live, singlet, dumpneg, CD19+CD43+IgMhi IgDlo/neg cells. (B) Mean frequencies ± SD. IgM ASCs among total and Blimp-1 YFPneg B-1a and 
B-1b cells in the BM (n = 4). The dashed line represents the limit of detection. Results are representative of two independent experiments. (C) Prdm1, irf4, 
zbtb20, and igj (J chain) mRNA expression (Log) ± SD by FACS-sorted follicular B cells (FO B), BM B-1 cells, and B-1PCs, normalized to ubc (n = 3). Results 
are combined from two independent experiments. (D) Fluorescent imaging of (left to right) FACS-sorted B-1PCs (first column) and BM B-1 cells either 
showing (second column) or not showing (third column) intracellular IgM staining, all taken from Blimp-1 YFP reporter mice and B-1PCs (fourth column) 
taken from C57BL/6 mice. Top to bottom: differential interference contrast images, Blimp-1 YFP (green), intracellular IgM (red), and merged images. Arrows 
indicate intracellular IgM vesicles. Smaller blue boxes indicate the magnified area found in the larger blue box in the same image. The scale bars (25 µm) 
in the top left image apply to all images. FMO, fluorescence minus one control stains for intracellular IgM (fifth column). C57BL/6 B-1PCs serve as FMO for 
YFP expression and are stained with anti–GFP/YFP-FITC. Images are representative of multiple cells from two independent experiments. Statistics in B and 
C were done using an unpaired Student’s t test (*, P < 0.05; **, P < 0.005; ***, P < 0.0005).
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PRDM-1ΔEx1A and control mice. Surprisingly, IgG3 secretion 
by B-1 cells was mostly Blimp-1–independent, explaining the 
normal serum IgG3 levels in PRDM-1ΔEx1A mice.
Multiple lines of evidence suggest that Blimp-1neg ASCs 
are not simply precursors of Blimp-1–expressing cells. First, 
Blimp-1neg IgM ASCs in BM are able to secrete as much an-
tibody as total BM IgM ASCs, as shown in ELI SPOT and in 
culture experiments, when comparing IgM secretion by B-1 
cells from PRDM-1ΔEx1A and control mice and comparing 
sorted Blimp-1 YFPpos and YFPneg B-1 cells. The data indicate 
that Blimp-1 is not needed for maximal IgM secretion by 
these cells. Second, most natural IgG3 ASCs lacked Blimp-1 
expression and, correspondingly, serum IgG3 levels in 
PRDM-1ΔEx1A mice were comparable to those of the controls. 
Class switching away from IgM to another isotype requires 
activation and induction of AID expression (Muramatsu et 
al., 2000), stimulated by signals mediated through the BCR, 
TLR, or CD40L (Keim et al., 2013). Thus, IgG3-secreting 
cells must have received activation signals to class switch to 
IgG3, yet most remain Blimp-1neg. This suggests that an alter-
Figure 8. PrdM-1ΔEx1A BM B-1 cells can increase frequencies of IgM Ascs. (A) Mean frequencies ± SD of IgM ASCs among BM cells from control 
and PRDM-1ΔEx1A mice (n = 11) and (B) control and PRDM-1ΔEx1A IgMb peritoneal cavity donor chimeras (n = 4–9). (C, left) Mean spot sizes ± SD (number of 
pixels) for control and PRDM-1ΔEx1A mice (n = 3) and (C, right) representative ELI SPOT wells. Numbers indicate total input cell count. Results are representa-
tive (A and C) or pooled (B) from two independent experiments. (D) Mean B-1–derived IgM ± SD (µg/ml) in supernatants of cultured BM cells from control 
and PRDM-1ΔEx1A B-1 peritoneal cavity donor chimeras as measured by ELI SA (n = 3–5). (E) Mean frequencies ± SD of IgM ASCs among BM CD19neg CD43+ 
IgM+ IgDlo/neg CD138+ B-1PC and CD19+ CD43+ IgM+ IgDlo/neg B-1 cells and (F) B-1a and B-1b cells in control and PRDM-1ΔEx1A mice (n = 5–8). (G, left) Mean 
maximum IgM spot sizes ± SD (number of pixels) of sorted Blimp-1 YFP+ and YFPneg B-1a and B-1b cells (n = 2 for control mice; n = 3 for PRDM-1ΔEx1A 
mice) and (G, right) representative ELI SPOT wells. Numbers indicate total input cells. (H) Total numbers ± SD of live BM B-1a and B-1b cells calculated based 
on total live cell counts and percentages of B-1a and B-1b cells (n = 3). Results in E–H are representative of two independent experiments. Statistics for all 
panels were done using an unpaired Student’s t test (*, P < 0.05; **, P < 0.005).
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native activation/differentiation pathway exists that supports 
antibody secretion and is used in the Blimp-1neg ASCs.
All B-1 cells exhibit signs of activation: They are larger 
and contain a greater amount of cytoplasm than follicular B-2 
cells, consistent with being in an activated state. In contrast 
to follicular B cells, but similar to plasma blasts, B-1 cells in 
the spleen and BM express CD43, a marker of B cell dif-
ferentiation, and they show increased surface expression of 
the costimulatory molecules CD80/CD86. Because natural 
IgM secretion is not affected by microbiota or infections, as 
demonstrated by studies in germ-free mice, the induction 
of this activation state is likely the outcome of interaction 
with self-antigens. It is possible that the timing or location of 
activation by self-antigens, or the specific properties of the 
self-antigen, determines whether cells will differentiate along 
the Blimp-1–dependent or Blimp-1–independent pathway. 
Alternatively, distinct subsets of B-1 cells may exist that differ 
in their ability to induce Blimp-1.
B-1 cells develop from multiple fetal, neonatal, and adult 
tissues (Herzenberg et al., 1986; Solvason et al., 1991; Kantor 
et al., 1992; Godin et al., 1993; Düber et al., 2009; Esplin et 
al., 2009; Holodick et al., 2009; Ghosn et al., 2012; Kobayashi 
et al., 2014). They have precursors of both hematopoietic and 
nonhematopoietic origins (Kantor et al., 1992; Kobayashi et 
Figure 9. natural IgG3 is secreted independently 
of Blimp-1. (A) Shown are serum Ig isotype concentra-
tions ± SD (mg/ml) in control and PRDM-1ΔEx1A mice (n = 
5–9 for IgA, IgG1, IgG2c, and IgG2b; n = 12–15 for IgG3). 
Results are pooled from two independent experiments. 
(B) Mean frequencies ± SD of IgG3 ASCs among the 
spleens and BM from control and PRDM-1ΔEx1A mice (n = 
3). (C, left) Mean spot sizes ± SD (number of pixels) from 
IgG3 ASCs in the spleens of control and PRDM-1ΔEx1A 
mice (n = 3) and (C, right) representative ELI SPOT wells. 
Numbers indicate total input cells. Results in B and C 
are representative of two independent experiments. (D) 
Serum IgG3 (mg/ml) ± SD in mice with only B-1 cells 
(neonatal chimeras, day 42, during DS-1 treatment) 
and in the same mice after reconstitution of B-2 cells 
(day 94). Each line represents one mouse. Results are 
combined from two independent experiments. (E, left) 
Sample gating for total IgG3+ and IgG3neg cells, as well 
as IgG3+ Blimp-1 YFP+ and YFPneg cells, pregated on live, 
singlet, and dumpneg cells. FMO, fluorescence minus one 
control stains for IgG3. Values shown in FACS plot rep-
resent percentage within parent population. Cells were 
sorted directly into ELI SPOT plates. (E, right) Mean fre-
quencies ± SD of IgG3 ASCs among splenic IgG3+ (total), 
IgG3+ Blimp-1 YFP+ (YFP+), and IgG3+ YFPneg (YFP-) and 
IgG3neg cells (n = 4–8). The dashed line represents the 
limit of detection. (F, left) Mean spot sizes ± SD (number 
of pixels) from splenic IgG3+ Blimp-1 YFP+ and IgG3+ 
YFPneg cells (n = 3) and (F, right) representative ELI SPOT 
wells. Results in E and F are representative of three inde-
pendent experiments. Statistics in A–C and F were done 
using an unpaired Student’s t test (*, P < 0.05).
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al., 2014). Whether each of these sources contributes equally 
to all B-1 cell subsets is unclear. We found that both Blimp-1+ 
and Blimp-1neg natural ASCs can develop from adult peritoneal 
cavity B-1 cells. When transferred into a neonate lacking B-1 
cells, peritoneal B-1 cells are able to reconstitute all subsets of 
B-1 cells in the spleen and BM, including B-1PCs, Blimp-1–
dependent and Blimp-1–independent B-1 IgG3, and IgM 
ASCs. However, whether an individual B-1 cell precursor can 
form all of these cells or whether the B-1 precursor population 
is heterogeneous remains to be studied. Montecino-Rodriguez 
and Dorshkind (2012) recently proposed that B-1 cells develop 
in waves arising from the yolk sac, fetal liver, and fetal BM. These 
waves of B-1 cells could be contributing distinct precursor 
populations, which develop into cells that phenotypically look 
very similar but rely on different regulatory pathways for dif-
ferentiation, to the B-1 cell pool. Castro et al. (2013) reported 
on a similar dichotomy of Blimp-1 dependence and indepen-
dence among IgM-secreting cells of the shark. Thus, both the 
Blimp-1–dependent and Blimp-1–independent pathways of B 
cell differentiation might be well conserved in evolution.
An important avenue for future exploration raised 
by these studies is to define the molecular signature of 
Blimp-1neg ASCs. To address this question, significant tech-
nical challenges must be overcome—in particular, the low 
frequency of these cells among the pool of nonsecreting 
B-1 cells, as well as the lack of a marker that can cleanly 
distinguish Blimp-1neg–, IgM–, and IgG3–secreting from 
nonsecreting cells. Although Blimp-1 is a key molecule of 
the PC gene network, this does not preclude the presence 
of other genes regulating antibody secretion by B cells. The 
fact that IgM-secreting B-1 cells continue to express CD19, 
a target gene activated by BSAP in B-2 cells but suppressed 
by Blimp-1 through its repression of BSAP, suggests that 
antibody-secreting B-1 cells, including those expressing 
Blimp-1, differ in their transcriptional profile from PCs. 
Another important function of Blimp-1 is the repression 
of PAX5, which, among other effects, drives expression of 
sXBP-1 in support of the unfolded protein response of 
secreting cells and thus regulates ER stress (Nutt et al., 
2015). However, B-1 cells express reduced levels of PAX5 
compared with follicular B cells (Tumang et al., 2005; Choi 
et al., 2012), which may help to facilitate up-regulation of 
sXBP-1 independent of Blimp-1.
Further studies are required to determine the unique 
gene expression profile of the natural antibody-secreting 
Blimp-1neg B cell pool.
In summary, our data demonstrate that a heterogeneous 
pool of Blimp-1–dependent and Blimp-1–independent nat-
ural antibody-secreting B-1 cells contribute to serum IgM 
and IgG3 production. Further exploration of the differences 
between these distinct populations of natural ASCs may lead 
to more targeted therapeutics for diseases and conditions such 
as autoimmune diseases, atherosclerosis, and chronic inflam-
mation that might be treated through induction of enhanced 
natural antibody production.
MAtErIAls And MEtHods
Mice
8–16-wk-old male and female C57BL/6J mice and 
breeding pairs of B6.Cg-Gpi1aThy1aIgha/J (Igha), 
B6.129S2-Ighmtm1Cgn/J (µMT), and B6.SJL-PtprcaPepcb/
BoyJ (CD45.1) were purchased from The Jackson Laboratory. 
B6.Cg-Tg(PRDM1-EYFP)1Mnz (Blimp-1 YFP) breeders 
were provided by M. Nussenzweig (The Rockefeller Uni-
versity, New York, NY). PRDM-1ΔEx1A breeders were pro-
vided by E. Bikoff (University of Oxford, Oxford, England, 
UK). B6.129S-sIgM−/− (μs−/−) breeders were a gift from F. 
Lund (University of Alabama at Birmingham [UAB], Bir-
mingham, AL). Swiss Webster germ-free mice were provided 
by A. Bäumler (University of California, Davis [UC Davis], 
Davis, CA), and age/sex-matched Swiss Webster controls 
were purchased from Taconic.
For experiments involving CD19cre/+ mice, C57BL/6, 
CD19cre/+, and CD19cre/+ PRDM-1flx/flx mice were housed at 
UAB. Mice were of mixed sexes, and all mice were age-matched. 
Mice were bred and maintained under SPF conditions in mi-
croisolator cages and were euthanized by overexposure to car-
bon dioxide. All procedures and experiments involving animals 
were approved by the Animal Use and Care Committee of UC 
Davis and UAB. Unless otherwise indicated, all “control” mice 
were age- and sex-matched C57BL/6J mice (The Jackson Lab-
oratory) and were housed for at least 1 wk in our mouse facility.
Neonatal chimeric mice were generated as previ-
ously described (Baumgarth et al., 1999). In brief, neonatal 
B6.Cg-Gpi1aThy1aIgha mice were injected i.p. with 0.1 mg 
of DS.1 antibody (anti-IgMa) 1–2 d after birth to deplete host 
B cells and twice weekly after that for 6 wk. On day 2 or 3 
after birth, they received i.p. total peritoneal and pleural cavity 
lavage cells or highly purified B-1 cells from congenic donor 
Ighb mice. After the last antibody injection, chimeras were 
rested for at least 6 wk to allow for host B cell reconstitu-
tion. In these mice, most B-1 cells are donor derived (Ighb), 
whereas all conventional B cells are host derived (Igha). For 
PRDM-1ΔEx1A chimeras, C57BL/6 mice were used as the do-
nors to make control chimeras.
Infections and injections
Influenza A/Puerto Rico/8/34 (A/PR/8, H1N1) was grown 
and harvested as previously described (Doucett et al., 2005). 
Mice were anesthetized with isoflurane and infected with a 
previously titrated dose of the virus in 40 µl PBS.
For passive protection experiments, serum was collected 
from the control and PRDM-1ΔEx1A mice and IgM concen-
trations determined by ELI SA. Serum containing 25 μg of 
IgM diluted in PBS (200 μl total volume) was injected into 
the lateral tail vein of groups of B cell–deficient μMT mice 
2 h before influenza infection.
qrt-Pcr
For viral load measurements, whole lungs were collected 24 h 
after infection with Influenza A/PR/8 and placed into an M 
2791JEM Vol. 214, No. 9
tube (Miltenyi Biotec) on ice containing 1 μl of PBS. Lungs 
were processed using a gentleMACS dissociator (Miltenyi 
Biotec) until homogenized. Samples were centrifuged for 5 
min at 600 g, and supernatants were frozen at –80°C.
Viral RNA was isolated from lung supernatant using 
a QIAamp Viral RNA Mini kit (QIA GEN) per the man-
ufacturer’s instructions. cDNA was generated using random 
hexamer primers (Invitrogen) and SuperScript II reverse 
transcription (Invitrogen). qRT-PCR was performed using 
Influenza A primers AM-151/AM-397 and probe AM-245 
(Schweiger et al., 2000).
For gene expression, mRNA was isolated from cells 
using an RNeasy mini kit (QIA GEN) per the manufacturer’s 
instructions. cDNA was generated as previously described. 
For prdm1 expression in Fig. 5 F, qRT-PCR was performed 
on a 7900HT Fast Real-Time PCR system (Applied Bio-
systems) using Sybr Green Master Mix (Thermo Fisher Sci-
entific) and primers for gapdh (F: 5′-ACG GCC GCA TCT 
TCT TGT GCA-3′; R: 5′-AAT GGC AGC CCT GGT GAC 
CA-3′) and prdm1 (F: exon 5, 5′-GGC TCC ACT ACC CTT 
ATC CTG-3′; R: exon 6, 5′-TCC TTT TGG AGG GAT TGG 
AGTC-3′). In Fig. 6 C, qRT-PCR was performed using com-
mercially available TaqMan primer/probe mixes (Thermo 
Fisher Scientific) for prdm1, irf4, zbtb20, igj, and ubc. For 
igj expression in follicular B cells, only one of three samples 
gave a positive signal. To allow for graphical representation of 
Ct(gene)–Ct(ubc), the two negative samples were given the 
maximum Ct value of 40.
Flow cytometry
Single-cell suspensions from tissues were obtained by grinding 
tissues between the frosted ends of two glass slides and were 
stained as described previously (Rothaeusler and Baumgarth, 
2006). BM cells were obtained from the tibia, fibula, and hu-
merus by flushing the bones with “staining media” (Rothae-
usler and Baumgarth, 2006) using a 27-g needle. Peritoneal 
cavity washout was collected by injecting the peritoneal cav-
ity with staining media using glass Pasteur pipettes and a bulb, 
agitating the cavity, and extracting the fluid. Single-cell sus-
pensions were treated with ACK lysis buffer (Rothaeusler and 
Baumgarth, 2006) to lyse red blood cells. Fc receptors were 
blocked with anti-CD16/32 antibody (2.4G2), and cells were 
stained on ice with the following fluorochrome conjugates: 
CD19–Cy5PE (clone ID3), CD4 (GK1.5)–, CD8a (53-6.7)–, 
CD90.2 (30H12.1)–, F4/80 (F4/80)–, Gr-1 (RB68C5)–, and 
NK1.1 (PK136)–Pacific blue, IgM (331)–Cy7-allophycocyanin, 
allophycocyanin, FITC, biotin, IgMa (DS-1.1)-allophycocyanin, 
IgMb (AF6-78.2.5)-allophycocyanin, IgD (11-26)-Cy7PE, 
IgDa (AMS-9.1.1)-Cy7PE, IgDb (AF6-122)-Cy7PE, CD138 
(281-2)-allophycocyanin, CD45.1 (A20)-FITC, CD43 
(S7)-PE, APC, Pacific blue, CD5 (53-7.8)-biotin, PE, CD23 
(B3B4.2)-FITC, biotin, BP1 (6C3-6)-FITC, B220 (RA3-6B2)-
Cy7APC, FITC (all generated in-house); IgG3-biotin (BD, 
R40-82), CD138-BV605 (BD), CD21-BV605 (BD), CD45R-
efluor780 (eBioscience), CD19-BV786 (BD), CD93-PE (BD), 
CD24-BV711 (BD), Streptavidin–Qdot 605 (Thermo Fisher 
Scientific), and Streptavidin-allophycocyanin (eBioscience). 
Dead cells were identified using Live/Dead Fixable Violet or 
Live/Dead Fixable Aqua stain (Invitrogen). FACS analysis was 
done using a 4-laser, 22-parameter LSR Fortessa (BD). Cells 
were sorted using a three-laser FAC SAria (BD) as described by 
Rothaeusler and Baumgarth (2006). A 100-µm nozzle was used 
for sorting, and pressure was set to 18 psi. Data were analyzed 
using FlowJo software (FlowJo LLC; provided by A. Treister, 
Treestar Inc., Ashland, OR).
Brdu incorporation
BrdU staining was performed as described previously (Roth-
aeusler and Baumgarth, 2006). For B-1a, B-1b, and B-1PC 
turnover rates, mice were injected i.p. for 2 d with BrdU (BD). 
Overall percent BrdU incorporation was determined in each 
population, and percentages were divided by 2 to determine 
turnover per day. Spleen and BM cells were stained for surface 
markers as described previously. Cells were fixed for 30 min 
on ice with Cytoperm/Cytofix (BD) and were frozen over-
night at –80°C in 90% FBS/10% DMSO. Cells were thawed 
within 7 d, refixed with Cytoperm/Cytofix, and treated for 
1 h with 25 U/6.25 × 106 cells of DNase I at 37°C (Worth-
ington Biochemical Corporation). Cells were then stained at 
room temperature with anti–BrdU-FITC (BD).
Fluorescent microscopy
Spleen and BM cells from Blimp-1 reporter mice and 
C57BL/6 mice were stained as described above with CD19-
Cy5PE (clone ID3), CD4 (GK1.5)–, CD8a (53-6.7)–, F4/80 
(F4/80)–, Gr-1 (RB68C5)–, and NK1.1 (PK136)–Pacific 
blue, IgM (331)-PE, IgD (11-26)-Cy7PE, and CD43 (S7)- 
allophycocyanin (for reporter mice) or CD138 (281-2)- 
allophycocyanin (for C57BL/6 mice). Cells were then fixed 
with Cytofix/Cytoperm and stained intracellularly with anti–
GFP-FITC (Abcam) and IgM (331)–Alexa Fluor 594. B-1 
cells (DumpnegCD19+IgMhiIgDloCD43+YFPneg) and B-1PC 
(DumpnegCD19negIgMhiIgDloCD43+YFP+) cells were sorted 
as described above from Blimp-1 YFP mice. In C57BL/6 
mice, DumpnegCD19negIgMhiIgDloCD138+ and Dumpneg 
CD19+IgMhiIgDloCD138neg cells were sorted as non–
YFP-expressing controls for B-1PC and B-1–like cells.
Cytospin preparations were made for each sorted pop-
ulation, and cells were mounted using Merifluor Mounting 
Medium (Meridian Diagnostics). Images were collected on 
an Olympus BX61 microscope with an Olympus DP72 
color camera and were processed with ImageJ (National In-
stitutes of Health) software.
Magnetic cell purification
For experiments culturing peritoneal cavity B cells, au-
toMACS (Miltenyi Biotec) was used to purify CD19+ cells. 
Cells were labeled with CD19-biotin, then with anti-biotin 
magnetic microbeads (Miltenyi Biotec). Purities were >95% 
as determined by flow cytometry.
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To purify peritoneal cavity B-1 cells, autoMACS de-
pletion was used. Cells were labeled and run on autoMACS 
as above, with biotinylated CD4, CD8a, Gr-1, F4/80, and 
NK1.1. The negative fraction was washed into PBS for in-
jection. Purity was >90% as determined by flow cytometry.
tissue cultures
For measurement of prdm1 expression and secreted IgM in 
culture supernatant, 2.5 × 105 live cells/well counted using a 
hemocytometer and Trypan blue were plated into 96-well U 
bottom tissue culture plates (BD). If indicated, LPS was added 
at 10 µg/ml. Cells were incubated for 3 d at 37°C/5% CO2. 
Supernatants were collected and stored at –20°C until use. 
Cells were immediately processed for mRNA.
ElI sPots
IgM ASCs were enumerated as described previously (Dou-
cett et al., 2005). In brief, anti-IgM (331) or anti-IgG3 
(Southern Biotech) was coated overnight onto 96-well plates 
(Multi-Screen HA Filtration, EMD Millipore). Plates were 
blocked with PBS/4% BSA. Live cells counted using Trypan 
blue exclusion were either serially diluted twofold into the 
ELI SPOT plate in culture media (RPMI 1640 [Gibco], 10% 
heat-inactivated fetal bovine serum, 292 µg/ml l-glutamine, 
100 units/ml penicillin, 100 µg/ml streptomycin, 50  µM 
2-mercaptoethanol) or were directly deposited by FACS 
into culture media–containing wells. Plates were incubated 
overnight at 37°C/5% CO2. IgM binding was identified 
with biotinylated anti-IgM (SouthernBiotech), biotinylated 
anti-IgMa (BD), biotinylated anti-IgMb (BD), or bioti-
nylated anti-IgG3 (SouthernBiotech), followed by Strepta-
vidin–Horseradish Peroxidase (Vector Laboratories) and the 
substrate 3-amino-9-ethylcarbazole (Sigma-Aldrich). Spots 
were enumerated, and spot sizes, expressed as the number 
of pixels, were determined using the AID EliSpot Reader 
System (Autoimmun Diagnostika). Total BM spots were cal-
culated based on the assumption that one femur = 12.7% of 
total BM cells (Benner et al., 1981).
ElI sA
Sandwich ELI SAs were performed as previously described 
(Rothaeusler and Baumgarth, 2006). In brief, 96 well plates 
were coated with isotype-specific anti-Ig (SouthernBiotech). 
Nonspecific binding was blocked with blocking buffer (PBS, 
1% heat-inactivated NCS, 0.1% dried milk powder, 0.05% 
Tween20). Twofold serial dilutions in PBS of Ig isotype stan-
dards (SouthernBiotech), IgMa (purified from Igha C57BL/6 
mice), IgMb (CBPC112), serum samples, and culture superna-
tants were added to the plate at previously determined optimal 
predilutions. Binding was revealed using isotype-specific bi-
otinylated anti-Ig (SouthernBiotech), anti-IgMa, or anti-IgMb 
(BD), followed by Streptavadin–Horseradish Peroxidase (Vec-
tor Laboratories), all diluted in blocking buffer. Plates were de-
veloped with 0.005% 3,3′, 5,5′-tetramethylbenzidine (TMB) 
in 0.05 M of citric acid with 0.015% hydrogen peroxide, and 
the reaction was stopped with 1 N of sulfuric acid. Absor-
bance was measured at wavelengths of 450 nm, with reference 
wavelengths of 595 nm using the SpectraMax M5 (Molecular 
Devices). Antibody concentrations were determined by com-
paring them to the standards.
statistical analysis
Statistical analysis was done using a two-tailed Student’s t test 
with the help of Prism software (GraphPad Software). P < 
0.05 was considered statistically significant.
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